KIDRON MIRIAM (Chief Scientific Officer) received a stock award from ORAMED PHARMACEUTICALS INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 2 awards
Filed: 1/5/2026ACC: 0001213900-26-001279
DirectorOfficer· Chief Scientific Officer
Since Feb 2019
+255.33K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
3
Total transactions
255.33K acquired
Non-Derivative Transactions2
Common Stock
Direct
Shares
+121.33K
Price / share
—
Trade value
—
% of position
10.2%
12/31/2025
1.19M→1.31M
Common Stock
Direct
Shares
+115K
Price / share
—
Trade value
—
% of position
8.7%
12/31/2025
1.31M→1.43M
Total
Net shares
+236.33K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/31/2025 | A · Award | +121.33K | — | — | 10.2% | 1.19M | 1.31M |
| Common Stock Direct | 12/31/2025 | A · Award | +115K | — | — | 8.7% | 1.31M | 1.43M |
| Total | +236.33K | $0.00 | ||||||
Derivative Transactions1
Performance Stock Units
Direct
Converts to
Common Stock
19K shares
Shares
+19K
Strike price
Held after
19K
Exercisable
—
12/31/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Performance Stock Units Direct | Common Stock19K shares | 12/31/2025 | A · Award | +19K | — | 19K |